在肺高血压中重新评估当前的缺铁定义
Aurelia E Reiser1, Markus Thiersch1, Max Gassmann1
1Institute of Veterinary Physiology, Vetsuisse Faculty University of Zürich Zurich Switzerland.
Pulmonary circulation
|July 30, 2025
概括
肺高血压 (PH) 中的缺铁 (ID) 有不同的定义. 转移素受体指数-ID (TFRI-ID) 与疾病严重程度标志物相关,与费里丁-ID或TSAT-ID不同.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 血液学 血液学 血液学
背景情况:
- 缺铁 (ID) 在肺高血压 (PH) 中很常见,但缺乏标准化的定义.
- 在PH中,ID定义和预后标记之间的相关性需要进一步研究.
研究的目的:
- 评估铁缺乏症的不同定义 (ferritin-ID,TSAT-ID,TFRI-ID) 以及它们与PH患者临床和血液动力学参数的相关性.
主要方法:
- 招募了94名PH患者,记录了临床/血液动力学数据和静脉血液样本.
- 定义的ID使用费里水平,转蛋白和度 (TSAT) 和转蛋白受体指数 (TFRI) 具有不同的值.
- 分析了ID定义和标记器之间的关联,例如平均肺动脉压 (mPAP),NT-proBNP和6分钟步行距离 (6MWD).
主要成果:
- 67%的患者符合费里-ID标准,35%的TSAT-ID和13%的TFRI-ID标准.
- TFRI-ID与显著更高的NT-proBNP水平相关 (p=0.004).
- TSAT-ID和TFRI-ID显示6MWD减少 (分别为p=0.006和p=0.052),而费里丁-ID则没有.
结论:
- 转激素受体指数-ID (TFRI-ID) 的定义似乎与PH严重性标志物比目前的费里-ID或TSAT-ID定义更强烈地相关.
- 需要进一步的研究来验证TFRI-ID用于识别PH患者的风险和指导铁替代疗法.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
291
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
291
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
319
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
319
Respiratory Assessment: Purpose and Indications
1.2K
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.2K
Rheumatic Heart Disease IV: Nursing Management
38
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
38
Pulmonary Embolism I: Introduction
46
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
46
Heart Failure VI: Adjunct Therapies
28
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
28


